By: Carol L. DiBerardino, Sara Kellner
Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.
Sara Kellner is a General Assignment Reporter for Healio, covering a wide range of topics in the medical field. With a focus on providing informative and engaging content, Sara's articles explore various aspects of healthcare, including research findings, treatment options, and emerging trends, to keep readers informed and updated.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sara Kellner's articles predominantly focus on healthcare and pharmaceuticals, with a significant emphasis on citing data. It appears that she covers a wide range of medical specialties, including cardiology, infectious diseases, ophthalmology, allergy/asthma, and mental health.
Given her reliance on cited data in reporting, Sara would likely be interested in sources who can provide credible statistical or research-based insights into the latest advancements within these medical fields. She may also benefit from interviews with experts involved in groundbreaking studies or clinical trials related to the topics she covers.
Sara does not seem to have a specific geographic focus but instead provides comprehensive coverage of medical developments across various regions. Therefore, pitches should emphasize the global significance or broader impact of the discussed medical findings.
This information evolves through artificial intelligence and human feedback. Improve this profile .